You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Tocilizumab prophylaxis

Showing 1 - 25 of 3,070
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Hematologic Malignancy Trial in Milwaukee (Tacrolimus, Methotrexate, Tocilizumab)

Active, not recruiting
  • Hematologic Malignancy
  • Milwaukee, Wisconsin
    Froedtert Hospital
Jan 31, 2023

Cytokine Release Syndrome, Stem Cell Transplant Complications Trial in Monterrey (Tocilizumab)

Completed
  • Cytokine Release Syndrome
  • Stem Cell Transplant Complications
  • Monterrey, Nuevo Leon, Mexico
    Hospital Universitario Dr. Jose E Gonzalez UANL
Mar 5, 2021

Covid-19 Trial in Huddinge (Anakinra Prefilled Syringe, Tocilizumab Prefilled Syringe, Standard-of-care treatment)

Recruiting
  • Covid-19
  • Anakinra Prefilled Syringe
  • +2 more
  • Huddinge, Stockholm, Sweden
    Karolinska University Hospital
Feb 17, 2021

Multiple Myeloma Trial (Teclistamab, Tocilizumab)

Not yet recruiting
  • Multiple Myeloma
  • (no location specified)
Jul 24, 2023

Coronary Artery Disease, Aortic Valve Disease Trial in Copenhagen (Tocilizumab, Isotonic sodium chloride (0.9%), Dexamethasone

Recruiting
  • Coronary Artery Disease
  • Aortic Valve Disease
  • Copenhagen, Denmark
    The Heart Centre, Rigshospitalet
Nov 29, 2022

Leukemia, Graft-versus-host-disease Trial in Hangzhou (Cytarabine, Busulfan, Cyclophosphamide)

Recruiting
  • Leukemia
  • Graft-versus-host-disease
  • Hangzhou, China
    The First Affiliated Hospital, College of Medicine, Zhejiang Uni
Dec 25, 2020

Follicular Lymphoma Trial in New York (Mosunetuzumab, Tazemetostat Pill)

Not yet recruiting
  • Follicular Lymphoma
  • New York, New York
    Weill Cornell Medicine/NewYork-Presbyterian Hospital
Aug 8, 2023

Recurrent Plasma Cell Myeloma, Refractory Plasma Cell Myeloma Trial in Atlanta (Tocilizumab, Venetoclax)

Recruiting
  • Recurrent Plasma Cell Myeloma
  • Refractory Plasma Cell Myeloma
  • Atlanta, Georgia
    Emory University Hospital/Winship Cancer Institute
Jan 24, 2023

Tocilizumab, Thyroid Associated Ophthalmopathy Trial in Guangzhou (Tocilizumab)

Recruiting
  • Tocilizumab
  • Thyroid Associated Ophthalmopathy
  • Guangzhou, Guangdong, China
    Zhongshan Ophthalmic Center
Oct 11, 2023

Retroperitoneal Fibrosis, Tocilizumab Treatment Trial in Beijing (Tocilizumab treatment, Prednisone Monotherapy)

Recruiting
  • Chronic Periaortitis
  • Tocilizumab Monotherapy
  • Tocilizumab monotherapy
  • Beijing, China
    Yunyun Fei
Oct 22, 2022

Giant Cell Arteritis Trial in Bonn (Methotrexate, Sodium chloride)

Recruiting
  • Giant Cell Arteritis
  • Bonn, Germany
    Medical Clinic and Polyclinic III Internal medicine Oncology, He
Dec 16, 2022

Lung Transplant Trial in Canada, United States (Tocilizumab, Placebo for Tocilizumab)

Not yet recruiting
  • Lung Transplant
  • Phoenix, Arizona
  • +16 more
Sep 8, 2023

Clinical Stage III Cutaneous Melanoma AJCC v8, Clinical Stage IV Cutaneous Melanoma AJCC v8, Locally Advanced Bladder Carcinoma

Recruiting
  • Clinical Stage III Cutaneous Melanoma AJCC v8
  • +41 more
  • Ipilimumab
  • +2 more
  • Houston, Texas
    M D Anderson Cancer Center
Oct 11, 2022

Sickle Cell Disease, Acute Chest Syndrome Trial (Tocilizumab)

Not yet recruiting
  • Sickle Cell Disease
  • Acute Chest Syndrome
  • (no location specified)
Nov 28, 2022

Coronavirus Infection, SARS (Severe Acute Respiratory Syndrome), Virus Diseases Trial in Cayenne (Tocilizumab, Dexamethasone)

Completed
  • Coronavirus Infection
  • +7 more
  • Cayenne, French Guiana
    CH Andrée Rosemon
Jun 7, 2022

Rheumatoid Arthritis Trial in China (Recombinant Humanized Anti-interleukin-6 Receptor Monoclonal Antibody Injection)

Completed
  • Rheumatoid Arthritis
  • Recombinant Humanized Anti-interleukin-6 Receptor Monoclonal Antibody Injection
  • Beijing, Beijing, China
  • +14 more
Jul 21, 2023

Cytomegalovirus Infections, Transplant-Related Disorder Trial in Philadelphia (Letermovir 480 MG [Prevymis])

Not yet recruiting
  • Cytomegalovirus Infections
  • Transplant-Related Disorder
  • Letermovir 480 MG [Prevymis]
  • Philadelphia, Pennsylvania
    Penn Medicine at the University of Pennsylvania
Sep 27, 2023

Metastatic Breast Cancer, Triple Negative Breast Cancer, Estrogen-receptor-low Breast Cancer Trial in Carmel, Indianapolis

Not yet recruiting
  • Metastatic Breast Cancer
  • +2 more
  • Carmel, Indiana
  • +2 more
Apr 27, 2023

Prostate Adenocarcinoma, Prostate Cancer, Localized Prostate Cancer Trial in San Francisco, Saint Louis (Atezolizumab,

Recruiting
  • Prostate Adenocarcinoma
  • +2 more
  • San Francisco, California
  • +1 more
Oct 8, 2022

Aneurysm, Behcet Syndrome, Vascular Type Trial in Beijing (tocilizumab, tofacitinib, cyclophosphamide)

Not yet recruiting
  • Aneurysm
  • Behcet Syndrome, Vascular Type
  • Beijing, Beijing, China
    Peking Union Medical College Hospital
Apr 26, 2023

Acute Myeloid Leukemia (AML) Trial in Nantes (Tocilizumab)

Active, not recruiting
  • Acute Myeloid Leukemia (AML)
  • Nantes, France
    CHU of Nantes
Dec 16, 2022

Myasthenia Gravis, Generalized Trial in China (Tocilizumab Injection)

Enrolling by invitation
  • Myasthenia Gravis, Generalized
  • Tocilizumab Injection
  • Beijing, Beijing, China
  • +5 more
Jan 27, 2023

Behcet's Uveitis Trial (Adalimumab, Tocilizumab)

Not yet recruiting
  • Behcet's Uveitis
  • (no location specified)
May 15, 2023

Diffuse Astrocytoma, IDH-Wildtype, Recurrent Glioblastoma Trial in United States (biological, procedure, radiation)

Suspended
  • Diffuse Astrocytoma, IDH-Wildtype
  • Recurrent Glioblastoma
  • Atezolizumab
  • +5 more
  • Los Angeles, California
  • +73 more
Jan 31, 2023

COVID-19 Trial in Chicago (Tocilizumab, Standard of Care)

Recruiting
  • COVID-19
  • Chicago, Illinois
    University of Chicago Medicine
May 11, 2022